NTAL inhibitors encompass a chemical class that specifically targets and impedes the activity of Non-T-cell Activation Linker (NTAL), also known as LAB or LAT2. NTAL is a transmembrane adaptor protein implicated in signal transduction processes, particularly in cells of the hematopoietic system such as mast cells and B cells. It is structurally similar to the Linker for Activation of T cells (LAT) protein, participating in the propagation of cellular signals following receptor engagement. NTAL inhibitors interact with the protein or its associated signaling pathways to suppress its function. The inhibition might occur through direct interaction with the NTAL molecule, effectively preventing it from associating with other signaling proteins. Alternatively, inhibitors could disrupt the lipid rafts where NTAL localizes, or they might interfere with the phosphorylation events that are essential for NTAL's role in signal transduction.
The impact of NTAL inhibitors on cellular functions is significant due to the role of NTAL in various signal transduction pathways. By curbing the activity of NTAL, these inhibitors can alter downstream signaling events that lead to cellular responses like degranulation, cytokine production, and cell proliferation. The precise mode of action of these inhibitors can involve the prevention of the recruitment of downstream effector molecules to the phosphorylated NTAL, or the alteration of the membrane dynamics critical for NTAL's function. The inhibition of NTAL can have diverse effects on cell behavior and the regulation of cellular responses, reflecting the multifunctional nature of NTAL in hematopoietic cell signaling.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Memantine hydrochloride | 41100-52-1 | sc-203628 | 50 mg | $69.00 | 4 | |
Approved for Alzheimer's, it regulates glutamate activity as an NMDA receptor antagonist. | ||||||
Dextromethorphan | 125-71-3 | sc-278927 sc-278927A sc-278927B | 10 g 100 g 500 g | $177.00 $1156.00 $5208.00 | 3 | |
Found in cough suppressants, it has NMDA receptor antagonist properties and is explored for neurological conditions. | ||||||
Agmatine sulfate | 2482-00-0 | sc-202920 sc-202920A | 100 mg 500 mg | $70.00 $182.00 | ||
A natural compound with potential neuroprotective and analgesic properties, modulating NMDA receptors. | ||||||
Felbamate | 25451-15-4 | sc-203579 sc-203579A | 10 mg 50 mg | $101.00 $373.00 | ||
An antiepileptic drug working partly through NMDA receptor inhibition. | ||||||
Riluzole | 1744-22-5 | sc-201081 sc-201081A sc-201081B sc-201081C | 20 mg 100 mg 1 g 25 g | $20.00 $193.00 $213.00 $317.00 | 1 | |
Approved for ALS, it inhibits NMDA receptors, reducing excitotoxicity. | ||||||
CGS 19755 | 110347-85-8 | sc-203882 sc-203882A | 10 mg 50 mg | $185.00 $781.00 | ||
Explored for brain injuries and stroke, it's an NMDA receptor antagonist, but clinical efficacy was limited. | ||||||
(−)-Huperzine A | 102518-79-6 | sc-200183 sc-200183A | 1 mg 5 mg | $143.00 $362.00 | 1 | |
Studied for Alzheimer's, it works partly as an NMDA receptor inhibitor. | ||||||
Lamotrigine | 84057-84-1 | sc-201079 sc-201079A | 10 mg 50 mg | $120.00 $486.00 | 1 | |
Antiepileptic and mood disorder agent in research, modulating NMDA receptors. | ||||||